Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein.

Sümeyye Koç Kerim Aslan Yüksel Terzi Ferah Kızılay Serkan Demir Dürdane Bekar Aksoy Fatma Kurtuluş Nuray Bilge Egemen Idiman Cihat Uzunköprü Serdal Güngör Vedat Cilingir Ethemoglu Ozlem Cavit Boz Haluk Gümüş Ahmet Kasim Kilic Ayşın Kısabay Ak Levent Sinan Bir Ömer Faruk Turan Soysa Aysun Mesrure Köseoğlu Gülnur Tekgöl Uzuner Hasan Bayındır Canbaz Kabay Sibel Mustafa Çam Vildan Yayla Hüseyin Tan Abdülcemal Özcan Özlem Taşkapıoğlu Muammer Korkmaz Yusuf Tamam Yılmaz İnanç Hüsnü Efendi Dilcan Kotan Mehmet Fatih Yetkin Adnan Burak Bilgiç Hikmet Saçmaci Serpil Demirci Yahya Çelik Turan Poyraz Murat Terzi

Published in: Balkan medical journal (2024)

For patients with NMOSD and without anti-NMO antibodies, the diagnosis is supported by the presence of anti-MOG-IgG. Furthermore, advanced age at clinical onset, Expanded Disability Status Scale (EDSS) score at clinical onset, spinal cord involvement, and number of attacks may be negative prognostic factors in patients with anti-MOG-IgG.

Keyphrases